Molecular rescue of tumour-specific T cell receptor idiotype from T cell lymphomas

被引：1

作者：

Reddy, SA ^{[1
]}

Levy, R ^{[1
]}

机构：

[1] Stanford Univ, Sch Med, Div Med Oncol, Stanford, CA 94305 USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2004年 / 124卷 / 05期

关键词：

idiotype; T cell receptor; rapid amplification of cDNA ends; T cell lymphomas; vaccines;

D O I：

10.1111/j.1365-2141.2004.04830.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The T cell receptor (TCR) idiotype on T cell lymphomas can serve as a vaccine target. To clone the relevant genes, 5' rapid amplification of cDNA ends (RACE) was performed on 13 T cell lymphomas and nine control samples. Two polymerase chain reactions (PCR) were performed for each TCR chain (alpha and beta) and the proportion of the clonal TCR sequence over the total number of TCR sequences was calculated. For alpha, the average proportions were 0.43 vs. 0.05. For beta these were 0.44 and 0.04. The TCR was identified in 10 of 13 lymphoma samples.

引用

页码：626 / 628

页数：3

共 50 条

[21] Influenza virus infection enhances tumour-specific CD8+ T-cell immunity, facilitating tumour control
Steinbach, Philine
Pastille, Eva
Kaumanns, Lara
Adamczyk, Alexandra
Sutter, Kathrin
Hansen, Wiebke
Dittmer, Ulf
Buer, Jan
Westendorf, Astrid M.
Knuschke, Torben
PLOS PATHOGENS, 2024, 20 (01)
[22] MOLECULAR-REARRANGEMENTS OF THE T-CELL RECEPTOR ALPHA-CHAIN GENE IN CUTANEOUS T-CELL LYMPHOMAS
LAROCHE, L
LARSEN, CJ
MATHIEUMAHUL, D
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1986, 87 (01) : 152 - 152
[23] NK cell depletion diminish tumour-specific B cell responses
Jensen, M
Tawadros, S
Sedlacek, HH
Schultze, JL
Berthold, F
IMMUNOLOGY LETTERS, 2004, 93 (2-3) : 205 - 210
[24] T-regulatory cells in tumour-specific vaccination strategies
Welters, Marij J. P.
Piersma, Sytse J.
van der Burg, Sjoerd H.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (09) : 1365 - 1379
[25] Obtaining tumour-specific T cells in a mouse melanoma model
Yuzhakova, D. V.
Izosimova, A.
Barbashova, L.
Zagaynova, E.
Sharonov, G.
Chudakov, D.
ANNALS OF ONCOLOGY, 2019, 30
[26] SEMAPHORIN 3A INCREASES TUMOUR-SPECIFIC T-CELL MEDIATED CYTOTOXICITY IN AN AUTOLOGOUS AND ALLOGENEIC SETTING
Figueiredo, Constanca
Schlahsa, Laura
Zhang, Haijiao
Goudeva, Lilia
Eiz-Vesper, Britta
Immenschuh, Stephan
Blasczyk, Rainer
TISSUE ANTIGENS, 2014, 84 (01): : 10 - 11
[27] T-cell receptor variable region genes in cutaneous T-cell lymphomas
Straten, PT
Ralfkiaer, E
Hendriks, J
Seremet, T
Vejlsgaard, GL
Zeuthen, J
BRITISH JOURNAL OF DERMATOLOGY, 1998, 138 (01) : 3 - 12
[28] Splenic myeloid cells tolerize tumour-specific T cells
Kirsty Minton
Nature Reviews Immunology, 2012, 12 (10) : 685 - 685
[29] Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma
Tan, Qin
Zhang, Chaoting
Yang, Wenjun
Liu, Ying
Heyilimu, Palashati
Feng, Dongdong
Xing, Liying
Ke, Yang
Lu, Zheming
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
[30] Altered T Cell Antigen-specific Receptor Signaling in Tumor Infiltrating T Cells in Follicular Lymphomas
Hsu, Faye
Irish, Jonathan
Sachs, Karen
Nolan, Garry
CLINICAL IMMUNOLOGY, 2010, 135 : S66 - S66

← 1 2 3 4 5 →